“This is simply astounding - not sure why it is not all over the press, it makes me very skeptical.”

CYDY has not released an official PR on the breast cancer trial(s) since the February timeframe and at that time the trial did not have 13 patients and did not have as much data as now. The previous cancer PRs were impressive, but had little information on only a few patients and this is why it is not covered by the press. I believe once the trial has more patients and more data, including progression free survival, the word will spread among the investment and oncology community.